Patients in Ireland logged shorter hospital stays and had fewer emergency department visits during the COVID-19 pandemic.
Germline polymorphisms can affect response to treatment in people with polycythemia vera.
The BLA is supported by data from the open-label, single-arm phase 2 KarMMa study.
Results of a perception survey revealed major deficits in education, screening, and treatment among patients with cancer.
An overall survival advantage with olaparib was particularly observed among patients with BRCA1 or BRCA2 alterations.
Patients with newly diagnosed AML who are ineligible for intensive chemotherapy may benefit from a 10-day course of decitabine with venetoclax.
A retrospective cohort study explored whether the low rate of resection for colorectal liver metastases is associated with lower survival rates among Black patients with CRC.
In Japan, insurance coverage for breast implantation is limited to procedures using Allergen-manufactured products.
Characterizing gene expression profiles of FL cells from intrafollicular and extrafollicular regions may help to identify future therapeutic targets.
Compared with sunitinib alone, nivolumab plus cabozantinib therapy was associated with a 49% decreased risk for progression and 40% decreased risk for death.
Survival was significantly improved in patients with greater disease burden.
In a study of men with mCRPC receiving chemotherapy and maximal androgen ablation, those who had an objective response to treatment had a significantly higher subcutaneous adipose tissue index than those who did not.
Oncology nurses’ knowledge of sexual health concerns and barriers to conversations between nurses and patients regarding sexual health were improved with a nurse-education workshop.
Study found adding immunotherapy to radiotherapy significantly improved OS after definitive surgery for primary tumor in patients with brain metastasis.
Genomic copy number instability predicted the risk of disease progression among patients with Barrett esophagus years beforehand.
Regardless of genotype, venetoclax with a hypomethylating agent yields strong response and survival outcomes among patients with treatment-naive or R/R AML.
In a review of data from the Nationwide Readmissions Database, researchers found that women with ovarian cancer classified as frail were at higher risk for need of intensive care, nonroutine discharge, and readmissions after surgery.
Among some patients with cancer-associated thrombosis, rivaroxaban may be a viable alternative to low-molecular-weight heparin.
The 2020 update highlights the importance of accurate diagnosis of upper tract urothelial carcinoma, risk stratification, close follow-up of patients receiving kidney-sparing management, and other key aspects of care.
Patients with chronic lymphocytic leukemia/small lymphocytic lymphoma who had an L265P MYD88 mutation were uncommon and had distinct features.